PAVmed
PAVM
15 hedge funds and large institutions have $2.55M invested in PAVmed in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
15% more funds holding
Funds holding: 13 → 15 (+2)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
10% less capital invested
Capital invested by funds: $2.84M → $2.55M (-$291K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$219K |
| 2 |
GWS
Glassman Wealth Services
Vienna,
Virginia
|
+$11.4K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$6.85K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$5.94K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$4.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
-$143K |
| 2 |
BlackRock
New York
|
-$2.74K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2K |
PAVM Hedge Fund Activity: Q3 2019 in Review
15 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q3 2019, worth a combined $2.55M — down 10% from $2.84M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PAVM positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $219K. The largest seller was Levin Capital Strategies, cutting an estimated $143K.
- 15 institutional investors held PAVmed (PAVM) as of Q3 2019, up from 13 in Q2 2019.
- Funds reported $2.55M of PAVmed stock for Q3 2019, down 10% quarter-over-quarter.
- 3 funds opened new PAVmed positions in Q3 2019 and 1 closed out, a net change of +2 holders.
- The largest PAVmed buyer in Q3 2019 was Vanguard Group, an estimated $219K added.
- The largest PAVmed seller in Q3 2019 was Levin Capital Strategies, an estimated $143K sold.
Based on aggregated 13F filings for Q3 2019.